RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...

Recently, AIM announced a comprehensive deployment to integrate the DeepSeek large model, particularly in vaccine development, utilizing DeepSeek in conjunction with generative models and deep ...

With the help of mRNA technology proven effective during the COVID era, researchers are now closer than ever to perfecting ...

Yet today, at what should be a celebration of this revolutionary technology’s potential, we find ourselves wondering about the future of mRNA research. The scientific community is watching if funding ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...

This study shows that RNA decay rather than the presence of premature termination codons triggers a TA-like response.

Only recently has the ribosome—one of the oldest molecular machines in evolutionary terms—been recognized as an active ...